Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 20% ± 4% | |
epithelial cell | 6 studies | 21% ± 5% | |
endothelial cell | 4 studies | 19% ± 2% | |
GABAergic neuron | 3 studies | 37% ± 11% | |
glutamatergic neuron | 3 studies | 48% ± 6% | |
dendritic cell | 3 studies | 19% ± 4% | |
transit amplifying cell | 3 studies | 28% ± 9% | |
astrocyte | 3 studies | 33% ± 10% | |
oligodendrocyte | 3 studies | 25% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1197.33 | 1445 / 1445 | 100% | 22.28 | 183 / 183 |
lung | 100% | 1219.11 | 578 / 578 | 100% | 17.48 | 1155 / 1155 |
breast | 100% | 1231.23 | 459 / 459 | 100% | 20.98 | 1117 / 1118 |
intestine | 100% | 1423.92 | 966 / 966 | 100% | 17.86 | 526 / 527 |
uterus | 100% | 1724.91 | 170 / 170 | 100% | 25.69 | 458 / 459 |
ovary | 100% | 1160.88 | 180 / 180 | 100% | 14.37 | 429 / 430 |
bladder | 100% | 1507.19 | 21 / 21 | 100% | 16.68 | 502 / 504 |
stomach | 99% | 1001.35 | 357 / 359 | 100% | 21.67 | 286 / 286 |
pancreas | 100% | 956.56 | 328 / 328 | 99% | 14.92 | 177 / 178 |
thymus | 100% | 1067.79 | 653 / 653 | 99% | 11.93 | 599 / 605 |
prostate | 100% | 1203.67 | 245 / 245 | 98% | 8.58 | 494 / 502 |
skin | 100% | 1351.37 | 1809 / 1809 | 97% | 13.36 | 460 / 472 |
brain | 97% | 539.76 | 2567 / 2642 | 100% | 12.06 | 705 / 705 |
kidney | 100% | 1204.76 | 89 / 89 | 95% | 10.46 | 859 / 901 |
adrenal gland | 100% | 651.43 | 258 / 258 | 89% | 6.48 | 205 / 230 |
liver | 98% | 495.65 | 221 / 226 | 79% | 6.52 | 320 / 406 |
adipose | 100% | 1221.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.67 | 29 / 29 |
spleen | 100% | 1280.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.64 | 1 / 1 |
blood vessel | 100% | 965.60 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 97% | 472.04 | 779 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 513.74 | 829 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 1411.86 | 880 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 6.06 | 67 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006271 | Biological process | DNA strand elongation involved in DNA replication |
GO_0071897 | Biological process | DNA biosynthetic process |
GO_0006298 | Biological process | mismatch repair |
GO_0006297 | Biological process | nucleotide-excision repair, DNA gap filling |
GO_0042276 | Biological process | error-prone translesion synthesis |
GO_1904161 | Biological process | DNA synthesis involved in UV-damage excision repair |
GO_0000731 | Biological process | DNA synthesis involved in DNA repair |
GO_0006261 | Biological process | DNA-templated DNA replication |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043625 | Cellular component | delta DNA polymerase complex |
GO_0016035 | Cellular component | zeta DNA polymerase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0003887 | Molecular function | DNA-directed DNA polymerase activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | POLD3 |
Protein name | POLD3 protein DNA polymerase delta subunit 3 DNA polymerase delta 3, accessory subunit DNA polymerase delta subunit 3 (DNA polymerase delta subunit C) (DNA polymerase delta subunit p66) (DNA polymerase delta subunit p68) |
Synonyms | KIAA0039 |
Description | FUNCTION: Accessory component of both the DNA polymerase delta complex and the DNA polymerase zeta complex . As a component of the trimeric and tetrameric DNA polymerase delta complexes (Pol-delta3 and Pol-delta4, respectively), plays a role in high fidelity genome replication, including in lagging strand synthesis, and repair. Required for optimal Pol-delta activity. Stabilizes the Pol-delta complex and plays a major role in Pol-delta stimulation by PCNA . Pol-delta3 and Pol-delta4 are characterized by the absence or the presence of POLD4. They exhibit differences in catalytic activity. Most notably, Pol-delta3 shows higher proofreading activity than Pol-delta4 . Although both Pol-delta3 and Pol-delta4 process Okazaki fragments in vitro, Pol-delta3 may also be better suited to fulfill this task, exhibiting near-absence of strand displacement activity compared to Pol-delta4 and stalling on encounter with the 5'-blocking oligonucleotides. Pol-delta3 idling process may avoid the formation of a gap, while maintaining a nick that can be readily ligated . Along with DNA polymerase kappa, DNA polymerase delta carries out approximately half of nucleotide excision repair (NER) synthesis following UV irradiation. In this context, POLD3, along with PCNA and RFC1-replication factor C complex, is required to recruit POLD1, the catalytic subunit of the polymerase delta complex, to DNA damage sites . Under conditions of DNA replication stress, required for the repair of broken replication forks through break-induced replication (BIR) . Involved in the translesion synthesis (TLS) of templates carrying O6-methylguanine or abasic sites performed by Pol-delta4, independently of DNA polymerase zeta (REV3L) or eta (POLH). Facilitates abasic site bypass by DNA polymerase delta by promoting extension from the nucleotide inserted opposite the lesion . Also involved in TLS, as a component of the tetrametric DNA polymerase zeta complex. Along with POLD2, dramatically increases the efficiency and processivity of DNA synthesis of the DNA polymerase zeta complex compared to the minimal zeta complex, consisting of only REV3L and REV7 . . |
Accessions | H0YD46 ENST00000531615.1 Q05BV7 ENST00000527458.5 [Q15054-2] ENST00000263681.7 [Q15054-1] Q15054 ENST00000530511.5 ENST00000532954.1 ENST00000532497.5 [Q15054-3] Q8WUF6 E9PRK3 H0YEX7 Q569I8 E9PNC0 E9PM91 ENST00000528481.5 ENST00000524752.1 |